The Association Between Overweight and Oocyte Diameter in Women Undergoing Vitro Fertilization

This study is not yet open for participant recruitment.
Verified August 2012 by Hillel Yaffe Medical Center
Sponsor:
Information provided by (Responsible Party):
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT01672931
First received: August 22, 2012
Last updated: NA
Last verified: August 2012
History: No changes posted
  Purpose

We believe that there is an association between BMI and oocyte diameter in women undergoing IVF treatments. We plan to measure the oocyte diameter in 2 groups of women undergoing IVF. One group will have BMI 20-25 and the other group will have BMI above 30.


Condition Intervention
Infertility
Obesity
Other: Oocyte Measurement

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Hillel Yaffe Medical Center:

Primary Outcome Measures:
  • Larger Size of Oocyte Diameter [ Time Frame: One year ] [ Designated as safety issue: No ]
    Oocyte will be measured in women undergoing IVF treatment


Estimated Enrollment: 60
Study Start Date: September 2012
Estimated Study Completion Date: September 2013
Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
BMI over 30
Women undergoing IVF with BMI over 30
Other: Oocyte Measurement
BMI 20-25
Women undergoing IVF treatments with BMI between 20-25
Other: Oocyte Measurement

  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Women undergoing IVF treatments

Criteria

Inclusion Criteria:

  • IVF treated patients
  • BMI between 20-25 or over 30

Exclusion Criteria:

  • Everyone else
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01672931

Contacts
Contact: Gai Shrem, MD 972-50-6793080 gai.shrem@gmail.com

Locations
Israel
Hillel Yaffe Medical Center Not yet recruiting
Hadera, Israel, 38100
Sponsors and Collaborators
Hillel Yaffe Medical Center
Investigators
Principal Investigator: Gai Shrem, MD Hillel Yaffe Medical Center
  More Information

No publications provided

Responsible Party: Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT01672931     History of Changes
Other Study ID Numbers: 0034-12 HYMC
Study First Received: August 22, 2012
Last Updated: August 22, 2012
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Infertility
Obesity
Genital Diseases, Male
Genital Diseases, Female
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on April 17, 2014